Ohio State will lead a $12M NIH-funded trial comparing BiPAP and HFNO to improve emergency respiratory care for patients with ...
A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National ...
A low-cost, widely available drug may offer new hope for patients with severe COVID-19. An international study led by the ...
A $12 million award from National Heart, Lung and Blood Institute (NHLBI) will help researchers at T College of Medicine ...
WASHINGTON (TNND) — Five years after the world essentially shut down in response to the Coronavirus Pandemic, there is still a lot we don’t know about COVID-19. One looming question surrounds one of ...
Cognitive behavioral therapy (CBT) and a program of physical and mental rehabilitation probably improve symptoms of long covid, but the effects are modest, finds a review of the latest evidence ...